X Long Zheng

Title: **Innovative Contributions of X Long Zheng in Biotechnology**

Introduction

X Long Zheng, a prominent inventor based in Wallingford, PA, has made significant strides in the field of biotechnology, particularly in the understanding and treatment of thrombotic thrombocytopenic purpura (TTP). With a total of two patents to his name, Zheng's work demonstrates a commitment to addressing complex medical challenges through innovative methodologies and compositions.

Latest Patents

Zheng's latest patents include:

1. **Human Monoclonal Autoantibodies to ADAMTS13 and Uses Thereof** - This invention relates to the development of compositions and methods utilizing anti-ADAMTS13 autoantibodies. It encompasses a composition consisting of isolated anti-ADAMTS13 autoantibody or its fragments. Additionally, methods for creating an in vivo model of TTP by introducing anti-ADAMTS13 autoantibodies into model organisms are described, along with the identification of anti-autoimmune reagents for the condition.

2. **Gain-of-Function ADAMTS13 Variants Resistant to Autoantibody Inhibition and Methods of Use Thereof** - This patent outlines compositions and methodologies aimed at treating TTP, focusing on variants of ADAMTS13 that demonstrate resilience to autoantibody inhibition.

Career Highlights

Throughout his career, Zheng has collaborated with esteemed institutions such as the University of Pennsylvania and The Children's Hospital of Philadelphia. His involvement in these organizations has provided him with a platform to advance his research and develop his innovative ideas further.

Collaborations

X Long Zheng has had the opportunity to work alongside notable colleagues including Donald L Siegel and Stephen Kacir. These collaborations have enhanced his research capabilities and contributed to the successful development of his patented inventions.

Conclusion

X Long Zheng continues to be a pivotal figure in the realm of biotechnology, with his patents reflecting a deep understanding of hematological disorders and their therapeutic potentials. Through his innovative work, Zheng is paving the way for improved treatment options for conditions such as TTP, underscoring the importance of continuous research and collaboration in the innovation ecosystem.